BREAKING: Aveo CFO Found Liable For Misleading Investors

Nov 20, 2018 - Law360
A Massachusetts federal jury found the former chief financial officer of Aveo Pharmaceuticals liable for civil securities fraud in Boston on Tuesday, saying he misled investors by failing to tell them the U.S. Food and Drug Administration had recommended a second clinical trial for Aveo's flagship kidney cancer drug, Tivo. Read More